Ratings by Roth/MKM (Max Masucci)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2026 | Nautilus Biotechnology | NAUT | New Coverage | Buy (N/A) |
0.96 (2.06) |
114.58% | Details | |
| 9/29/2026 | Rapid Micro Biosystems Inc | RPID | New Coverage | Buy (N/A) |
1.11 (0.76) |
-31.53% | Details | |
| 8/5/2026 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
5.30 (7.08) |
33.58% | Details | |
| 8/4/2026 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2026 | 908 Devices Inc. | MASS | New Coverage | Buy (N/A) |
7.13 (11.26) |
57.92% | Details | |
| 6/24/2026 | Biodesix | BDSX | New Coverage | Buy (N/A) |
19.16 (23.66) |
23.49% | Details | |
| 6/24/2026 | Castle Biosciences | CSTL | New Coverage | Buy (N/A) |
21.38 (31.96) |
49.49% | Details | |
| 6/24/2026 | Exagen | XGN | New Coverage | Buy (N/A) |
4.36 (7.72) |
77.06% | Details |
